How to buy Novanta stock (NOVT)

Novanta is a scientific & technical instruments business based in the US. Novanta shares (NOVT) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $153.46 – a decrease of 7.67% over the previous week. Novanta employs 2,900 staff and has a trailing 12-month revenue of around $922.8 million.

Our top picks for where to buy Novanta stock

Buy Novanta stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Novanta stock price (NASDAQ: NOVT)

Use our graph to track the performance of NOVT stocks over time.

Novanta shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$153.46
52-week range	$146.86 - $187.12
50-day moving average more info button	$171.50
200-day moving average more info button	$169.60
Wall St. target price	$164.78
PE ratio more info button	94.2229
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$1.66

Is it a good time to buy Novanta stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Novanta price performance over time

Historical closes compared with the close of $156.41 from 2024-12-18

1 week (2024-12-13)	-5.89%
1 month (2024-11-21)	-5.04%
3 months (2024-09-20)	-10.38%
6 months (2024-06-21)	-6.54%

1 year (2023-12-20)	-4.87%
2 years (2022-12-20)	12.48%
3 years (2021-12-21)	167.09
5 years (2019-12-20)	70.94%

Is Novanta stock undervalued or overvalued?

Valuing Novanta stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Novanta's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Novanta's P/E ratio

Novanta's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 94x. In other words, Novanta shares trade at around 94x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Novanta's PEG ratio

Novanta's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.11. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Novanta's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Novanta's EBITDA

Novanta's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $164.5 million.

The EBITDA is a measure of a Novanta's overall financial performance and is widely used to measure a its profitability.

Novanta financials

Revenue TTM	$922.8 million
Operating margin TTM	14.34%
Gross profit TTM	$378.6 million
Return on assets TTM	5.35%
Return on equity TTM	8.67%
Profit margin	6.52%
Book value	$20.67
Market Capitalization more info button	$5.6 billion

TTM: trailing 12 months

Novanta share dividends

We're not expecting Novanta to pay a dividend over the next 12 months.

Have Novanta's shares ever split?

Novanta's shares were split on a 1:3 basis on 28 December 2010 . So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Novanta shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for Novanta shares which in turn could have impacted Novanta's share price.

Novanta share price volatility

Over the last 12 months, Novanta's shares have ranged in value from as little as $146.86 up to $187.12. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Novanta's is 1.287. This would suggest that Novanta's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Novanta overview

Novanta Inc. , together with its subsidiaries, provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. The company operates through three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. The Precision Medicine and Manufacturing segment offers photonics-based solutions, including laser scanning, beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; wireless technologies, video recorders, and video integration technologies for operating room integrations; optical data collection and machine vision technologies; radio frequency identification technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions. The Robotics and Automation segment offers optical and inductive encoders, precision motors, servo drives and motion control solutions, integrated stepper motors, intelligent robotic end-of-arm technology solutions, air bearings, and air bearing spindles. The company sells its products through its direct sales force and distributors under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, General Scanning, ATI Industrial Automation, Celera Motion, IMS, MicroE, Applimotion, Zettlex, Ingenia, and Westwind brands.

Frequently asked questions

What percentage of Novanta is owned by insiders or institutions?
Currently 0.799% of Novanta shares are held by insiders and 103.733% by institutions. How many people work for Novanta?
Latest data suggests 2,900 work at Novanta. When does the fiscal year end for Novanta?
Novanta's fiscal year ends in December. Where is Novanta based?
Novanta's address is: 125 Middlesex Turnpike, Bedford, MA, United States, 01730 What is Novanta's ISIN number?
Novanta's international securities identification number is: US67000B1044 What is Novanta's CUSIP number?
Novanta's Committee on Uniform Securities Identification Procedures number is: 36191C106